Quantinno Capital Management LP

Position in NVCR — NovoCure Ltd

CIK 1759654 NEW YORK, NY

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,112,398

+$1,119,892 QoQ

Shares Held

2,487,376

+23.7% QoQ

Ownership

2.15%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Quantinno Capital Management LP holds $618,754,293 across 58 Medical Devices names. NVCR ranks #10 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	696,614	$71,521,359
2	MDT	Medtronic plc	730,567	$63,303,630
3	SYK	Stryker Corp	180,788	$59,405,128
4	EW	Edwards Lifesciences Corp	639,603	$51,219,408
5	PODD	Insulet Corp	224,951	$47,203,717
6	GMED	Globus Medical Inc	547,095	$47,137,705
7	BSX	Boston Scientific Corp	574,482	$36,048,745
8	ZBH	Zimmer Biomet Holdings, Inc.	396,076	$35,813,191

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,112,398	2,487,376	+23.7%	Shares	Sole	2026-05-15
2025-12-31	$25,992,506	2,010,248	+32.1%	Shares	Sole	2026-02-17
2025-09-30	$19,666,410	1,522,168	+11.2%	Shares	Sole	2025-11-14
2025-06-30	$24,362,201	1,368,663	+38.5%	Shares	Sole	2025-08-14
2025-03-31	$17,610,650	988,252	+235.4%	Shares	Sole	2025-05-12
2024-12-31	$8,780,242	294,639	+17.1%	Shares	Sole	2025-02-14
2024-09-30	$3,931,429	251,531	-29.0%	Shares	Sole	2024-11-14
2024-06-30	$6,071,831	354,456	+518.9%	Shares	Sole	2024-08-14
2024-03-31	$895,176	57,273	+125.1%	Shares	Sole	2024-05-14
2023-12-31	$379,849	25,442	+1402.8%	Shares	Sole	2024-02-14
2021-03-31	$223,780	1,693	0.0%	Shares	Sole	2021-05-17
2020-12-31	$292,956	1,693	-32.0%	Shares	Sole	2021-02-09
2020-09-30	$277,273	2,491	-50.2%	Shares	Sole	2020-11-16
2020-03-31	$336,834	5,002	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.